Vericel Corporation (VCEL) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.31B, a trailing price-to-earnings ratio of 95.9 and a free-cash-flow yield of 1.1%. Over the most recent reported fiscal year, revenue grew 16.4%.